Oridonin, a drug isolated from a medicinal herb, has shown potent anti-tumor effects in OSA, by reducing NRF2 and an antioxidant pathway, leading to apoptosis (80). This evidence concerns the gene NFE2L2 and obstructive sleep apnea syndrome.